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SUMMARY
Draft genome sequences for Schistosoma japonicum and S. mansoni are now available. The schistosome genome encodes
*13000 protein-encoding genes for which the functions of few are well understood. Nonetheless, the new genes represent
potential intervention targets, and molecular tools are being developed to determine their importance. Over the past
15 years, noteworthy progress has been achieved towards development of tools for gene manipulation and transgenesis of
schistosomes. A brief history of genetic manipulation is presented, along with a review of the field with emphasis on reports
of integration of transgenes into schistosome chromosomes.
Key words: Schistosomes, genetic manipulation, transgenesis, chromosome integration, germ line, retrovirus, murine
leukaemia virus, pseudotyped gammaretrovirus, transposon, piggyBac.
INTRODUCTION
Schistosomes are considered the most important of
the human helminth infections in terms of morbidity
and mortality. More than 200 million people are
infected with schistosomes and a further 800 million
are at risk of schistosomiasis in >75 countries in
tropical and sub-tropical latitudes. Treatment and
control of schistosomiasis rely on the anthelmintic
drug praziquantel, but there is concern that drug
resistance will appear. New interventions, including
vaccines, drugs and diagnostics, are needed for this
neglected tropical disease (Hotez et al. 2008; Brindley
et al. 2009, and references therein).
Draft genome sequences for Schistosoma japonicum
and S. mansoni were reported recently, a landmark
event that ushered in the post-genomic era for schisto-
somiasis (Schistosoma japonicum Genome & Func-
tional Analysis Consortium, 2009; Berriman et al.
2009; Han et al. 2009). Despite the abundant new
datasets, functional analysis of target genes to under-
pin new interventions for schistosomiasis requires
routine approaches for both reverse and forward
genetics. To date, functional genomics approaches
beyond conventional RNA interference have not
been available for schistosomes although reporter
plasmids and RNAs have been introduced to several
developmental stages (e.g. Davis et al. 1999;
Wippersteg et al. 2002b, 2005; Mourão et al. 2009;
Krautz-Peterson et al. 2010; Stefanic et al. 2010).
Functional genomics including somatic and germ-
line transgenesis are desirable because these tech-
niques facilitate validation of essential genes/gene
products to be targeted with drugs or vaccines (e.g.
van Ooij et al. 2008; Homann et al. 2009; Langridge
et al. 2009; Buguliskis et al. 2010). This review ad-
dresses genetic manipulation of schistosomes. More
specifically, this review focuses on reports of gen-
etic manipulation of schistosomes dealing with
approaches targeting integration of transgenes into
schistosome chromosomes.
BRIEF HISTORY OF GENETIC MANIPULATION
IN SCHISTOSOMES
Advances with genetic manipulation of parasitic hel-
minths including schistosomes have been reviewed
(Grevelding, 2006; Brindley and Pearce, 2007;
Kalinna and Brindley, 2007; Alrefaei et al. 2011;
Mann et al. 2011). In brief, transgenesis of schisto-
somes was pioneered by Davis and co-workers who
bombarded adult stages of S. mansoni with mRNA-
encoding firefly luciferase and a luciferase-encoding
plasmid (Davis et al. 1999). Subsequently,
Grevelding and colleagues undertook a series of
studies employing particle bombardment of
S. mansoni stages using plasmids co-precipitated on
gold beads. The plasmids encoded fluorescent re-
porter proteins and were driven by promiscuous
(e.g. HSP70) or tissue-specific gene promoters (e.g.
cathepsin F) from schistosomes (Wippersteg et al.
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2002a, b, 2003, 2005; Rossi et al. 2003; Dvorak et al.
2010).
Heyers and colleagues introduced plasmid DNA
(coated on gold beads) into miracidia, sporocysts and
adults of S. mansoni by particle bombardment
(Heyers et al. 2003). The plasmid construct encoded
green fluorescent protein (GFP) under control of the
S. mansoni HSP70 (heat shock protein 70 kDa) pro-
moter and termination elements (Wippersteg et al.
2002b). The bombarded larvae and adults expressed
GFP, and the transformed miracidia penetrated
and established in the intermediate snail host
Biomphalaria glabrata. Gold particles were detected
in the germ balls of parasites in snail tissue, indicating
feasibility of returning transformed parasites to the
developmental cycle, a step expected to be useful for
establishing lines of transgenic schistosomes.
Correnti and Pearce (2004) demonstrated that
square wave electroporation could introduce reporter
genes into schistosomes. Subsequently, the tech-
nique has found wide acceptance for introduction of
plasmids, long dsRNA, siRNA, virions and other
reporters into all three major species of human
schistosomes, S. mansoni (e.g. Morales et al. 2008;
Dvorak et al. 2010), S. japonicum (Zhao et al. 2008)
and S. haematobium (Rinaldi, unpublished). Square
wave electroporation has been successfully employed
to introduce nucleic acids into eggs, miracidia,
sporocysts, schistosomules and adult developmental
stages of schistosomes, frequently using a single pulse
of 125 volts for 20milliseconds, in 4mm gap pathway
cuvettes (e.g. Correnti et al. 2005; Faghiri and Skelly,
2009; Kines et al. 2010). Moreover, electroporation
has also been employed to develop a method to assess
for the presence of an active RNAi pathway by si-
lencing the exogenous reporter gene,firefly luciferase.
This straightforward approach offers investigators a
means to study the presence of a functional RNAi
pathway in less well known parasites and/or to detect
the activity of non-conventional interfering mol-
ecules such as short hairpin RNAs in schistosomes
(Rinaldi et al. 2008; Ayuk et al. 2011).
Findings reported by Grevelding and colleagues
are notable in relation to the introduction of trans-
genes into the germline of schistosomes (Grevelding,
2006; Beckmann et al. 2007). Plasmids (both super-
coiled and linear) encoding GFP were introduced
into miracidia by particle bombardment, after which
the transformed miracidia infected Biomphalaria
glabrata snails by the natural route. Investigation
of the cercariae (F0 generation) shed from the snails
and adult worms from hamsters infected with the
cercariae and of eggs (F1) from the rodents revealed
the presence of the GFP transgene. Miracidia har-
vested from eggs obtained from the livers of the
hamsters were used for snail infections and the re-
sulting cercariae were employed to infect hamsters to
derive subsequent schistosome generations, F2 and
F3. Molecular analyses of F2 and F3 cercariae or
adults failed to detect transgenes. Nonetheless,
the findings demonstrated that the transgenes were
passed from one developmental stage to the next
within one generation and, furthermore, from one
generation to the next. Since the germ cells are
considered to be the only invariable cell type in the
developmental cycle of the schistosome, the investi-
gators concluded that the transgenes were present in
the germline and their germline-transformation ap-
proach had succeeded. Loss or instability of the
transgene before (non-Mendelian) inheritance by
the F2 progeny likely occurred because transgenes
had not integrated into the schistosome genome, a
phenomenon well known with extrachromosomal
arrays of transgenes in Caenorhabditis elegans (see
Semple et al. 2010). Fig. 1 provides a time line - over
the past 15 years - of the pioneering and key advances
in the genetic manipulation of schistosomes.
SCHISTOSOME TRANSGENESIS WITH
INTEGRATION COMPETENT VECTORS
Although approaches to genetic manipulation of
schistosomes with non-integration competent vec-
tors have been informative, there are major advan-
tages to genomic integration of transgenes including
Mendelian inheritance, sustained transgene activity
and transgene-vectored RNA interference (see
Giordano-Santini and Dupuy, 2011). Several classes
of integration competent vectors enjoy utility in
functional genomics and gene therapy for a spectrum
of eukaryotes. These include transposons, gamma-
retroviruses, lentiviruses and recombinase systems
(e.g. see Mates et al. 2007; Damasceno et al. 2010;
Turan et al. 2011). Several of these are now being
actively investigated for utility in integrating trans-
genes into the schistosome genome (Alrefaei et al.
2011).
Retroviruses
Both simple and complex retroviruses (family
Retroviridae) are widely employed in functional
genomics and gene therapy biotechnologies (e.g. see
Hannon and Rossi, 2004; Petrus et al. 2010; Sliva and
Schnierle, 2010). The simplex retroviruses include
the genus Gammaretrovirus which includes the mu-
rine leukaemia virus (MLV). Complex retroviruses
include the genus Lentivirus which includes the pri-
mate pathogens, HIV and SIV. Attributes of retro-
viruses that advance their appeal as gene transfer
vectors include self-reliant infectious nature, ability
to integrate into the chromosomes of the infected cell,
potential to be modified to increase host cell range
and availability of numerous constructs from com-
mercial sources and academic colleagues.
For safety, retroviral vector systems are usually
employed in two components – the retroviral vector,
which does not encode viral proteins and the
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retrovirus packaging cell line, which provides the
viral proteins necessary for vector transfer.
Infectious, but replication incompetent virions are
released from transfected packaging cells. The virus
can infect target cells but cannot produce new virions
after integration into host chromosome because the
integrated provirus does not encode viral proteins
(Miller, 1992). The restricted host-cell range of retro-
viral vectors limits their use for stable gene transfer in
eukaryotic cells. To overcome this latter limitation,
Burns and colleagues pioneered to use of vesicular
stomatitis virus glycoprotein (VSVG) pseudotyped
murine leukaemia virus (MLV)-derived vectors in
which the retroviral envelope glycoprotein is replaced
by the glycoprotein (G) of the rhabdovirus, vesicular
stomatitis virus (VSV) (Burns et al. 1993). VSVG is
able to bind to phospholipids on membranes of eu-
karyotic cells at large, endowing the VSVG pseudo-
typed virion with a potentially very broad range of
target tissues and cells (Mastromarino et al. 1987;
Emi et al. 1991). VSVG pseudotyped virions can
infect non-mammalian cells including fish cell lines
that are ordinarily refractory to infection because they
do not express a cognate receptor for the envelope
(surface) protein ligands of the wild type virions.
In our laboratory it has been well established
that the infectious replication incompetent MLV
retrovirus pseudotyped with VSVG can transduce
S. mansoni leading to integration of retroviral trans-
genes into schistosome chromosomes (Kines et al.
2006, 2008, 2010; Rinaldi et al. 2011). This was
notable given it was thought that evolutionary
blocks would constrain the utility of MLV in non-
mammalian taxa (Dirks and Miller, 2001). The
MLV-derived vector pLNHX was modified to
include reporter genes (firefly luciferase or green
fluorescent protein) under the control of an endoge-
nous schistosome gene promoter – the RNA poly-
merase II (Pol II) schistosome actin gene promoter
or the RNA polymerase III (Pol III) Spliced Leader
(SL) RNA gene promoter. Constructs and the
plasmid encoding VSVG were employed to transfect
GP2-293 packaging cells modified to express the
MLV gag and pol genes (Mann et al. 2008). Eggs,
primary sporocysts, schistosomules and adult stages
of S. mansoni have been successfully transduced with
the VSVG pseudotyped MLV virions. Two-colour
immunofluorescence, Southern hybridization and
RT-PCR confirmed successful transduction of the
schistosomes by this gammaretrovirus. Furthermore,
an anchored PCR (retrotransposon-anchored PCR,
RAP) approach that employs primers specific for
multi-copy endogenous mobile genetic elements
interspersed in the schistosome genome was
Fig. 1. Schematic time line of advances on genetic manipulation of schistosomes. Key events are noted, with pioneering
or key reports cited.
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successfully deployed to locate integration junctions
of transgenes in the genome of S. mansoni, defini-
tively establishing the presence of proviral MLV
transgenes integrated into schistosome chromosomes
(Kines et al. 2008). In terms of promoters, schisto-
some actin, HSP70 and spliced leader (SL) gene
promoters, as well as the 5′-LTR of MLV, all were
found to drive transgene expression in virion-
transduced schistosomes (Kines et al. 2006, 2008).
It is likely that the schistosome cells transduced by
the virions were frequently tegumental and/or intes-
tinal cells (Mann et al. 2008). However, we have also
fragmented adult worms into several pieces before
exposing the (still visibly motile) fragments to
virions, which resulted in increased density of trans-
genes integrated into the schistosome chromosomes
(Rinaldi et al. 2011). Nonetheless, in order for herit-
able transmission to occur, germline transduction
would have to have taken place. The schistosome
egg represents an advantageous developmental stage
at which to direct transgenes (Kines et al. 2010;Mann
et al. 2011). Accordingly, we proceeded to transduce
schistosome eggs with VSVG-pseudotyped MLV
facilitated by electroporation. Square wave elec-
troporation was more effective in delivering VSVG-
pseudotyped MLV into schistosome eggs than
passive soaking. Quantitative PCR (qPCR) analysis
revealed that schistosome eggs electroporated with
virions had several fold more copies of provirus than
eggs simply soaked in virions (Kines et al. 2010).
These findings highlight the potential of the schisto-
some egg as a target into which to deliver chromo-
somal integration competent transgenes, aiming to
establish germline transgenesis in schistosomes.
VSVG-pseudotyped MLV has been employed
to transfer transgenes into S. japonicum; Yang et al.
(2010) transduced schistosomules (perfused from
rabbits) with retroviral transgene encoding human
telomerase reverse transcriptase (hTERT).RT-PCR,
in situ hybridization immunohistochemistry and
immunoblot analysis determined that S. japonicum
can be successfully transduced with VSVG-
pseudotyped MLV and that the MLV vector can
transport sizeable genes as cargo – the hTERT gene
was *3·5 kb in length (Yang et al. 2010). These
findings also suggested the tantalizing possibility of
using the hTERT transgene to immortalize cells from
schistosome tissues, utilizing the oncogenic potential
of hTERT to establish schistosome cell lines.
Transposons
Transposons are naturally occurring mobile genetic
elements that move by a cut-and-paste mechanism;
they are flanked by inverted terminal repeat (ITR)
sequences and mobilized by a transposase encoded
by their single open reading frame. There are *20
superfamilies of these Class II mobile genetic ele-
ments, with member species widespread throughout
eukaryote phyla (Feschotte and Pritham, 2007; Yuan
and Wessler, 2011). Several are known from schisto-
somes including examples of theMerlin and CACTA
groups (Berriman et al. 2009). Transposons can
frequently mobilize in species phylogenetically dis-
tant from where they were first isolated, a facility
which has been harnessed in functional genomics and
experimental gene therapy (Plasterk et al. 1999; Ivics
et al. 2009). Accordingly, it is feasible that exogenous
transposons might also mobilize in schistosomes and
thereby supply integration competent vectors for
functional genomics of schistosomes. Several well-
studied transposons including piggyBac, Hermes and
mariner, are transpositionally active in planarians
(Gonzalez-Estevez et al. 2003). In evolutionary
terms, it is notable that host-parasite interactions
play a key role in the horizontal transfer of trans-
posons across phyla (Gilbert et al. 2010).
The piggyBac transposon is used widely in func-
tional genomics and experimental gene therapy
(Gonzalez-Estevez et al. 2003; Balu et al. 2005;
Wilson et al. 2007). This transposon was isolated
from the genome of a moth. It is a short inverted
terminal repeat element of 2·5 kb in length with ITRs
of 13 bp in length and a single open reading frame
encodings the transposase. piggyBac exhibits precise
excision upon transposition and affinity for TTAA
target sites (Fraser et al. 1985, 1996; Cary et al. 1989;
Elick et al. 1996). Recently, it has been determined
that piggyBac is also active in schistosomes. Morales
and colleagues examined whether the piggyBac trans-
poson could deliver reporter transgenes into the gen-
omes of S. mansoni (Morales et al. 2007). Linearized
piggyBac donor plasmid carrying the firefly luciferase
gene as reporter cargo under the control of schisto-
some gene promoters – actin (pXL-BacII-SmAct-
Luc) or HSP70 (pXL-BacII-SmHSP70-Luc) –was
introduced together with mRNA encoding the
piggyBac transposase into cultured schistosomules
by square wave electroporation. Activity of the helper
transposase mRNA was confirmed by hybridization
of genomic DNA from the transformed schistosomes
to a luciferase gene probe. The hybridization signals
indicated that the piggyBac transposon had integrated
into numerous sites within schistosome chromo-
somes. Integration events were recovered using an
anchored PCR approach employing several endogen-
ous mobile genetic elements from the schistosome
genome as anchors, which revealed characteristic
piggyBac TTAA footprints in the vicinity of several
protein encoding genes, annotated as adenylosucci-
nate lyase, glutathione peroxidase 1 and glutathione
S transferase, as well as loci near endogenous
mobile genetic elements including Boudicca and
SR2. These findings provided the first direct evi-
dence of somatic transgenesis of schistosomes, or
indeed of any parasitic helminth. They demonstrated
the transpositional activity of piggyBac in schistoso-
mal tissues, expanding the host range of piggyBac to
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the digenetic trematodes. Very recently, we reported
that vector-based RNAi activity driven by transgene
cargo carried by the piggyBac vector pXL-BacII
(Ayuk et al. 2011) – see below.
Other integration competent vectors
We are unaware of reports of other integrated trans-
genes in schistosomes beyond the findings withMLV
and piggyBac (above). However, it is not unlikely that
other retrovirus and transposons, including endogen-
ous schistosome mobile genetic elements, could find
utility in genome studies of schistosomes. A potential
advantage of endogenous mobile genetic elements is
that they may not suffer infection blocks from host
restriction/innate immunity factors (e.g. Takeuchi
and Matano, 2008; Strebel et al. 2009). DNA site-
specific recombinases (SSRs), such as Cre, FLPe and
φC31, from bacteriophages of fungi, and other pro-
venances are influential tools for analyzing gene func-
tion in vertebrates (e.g. see Bischof and Basler, 2008)
and might also be active in schistosomes. Several are
now in service for site-specific gene manipulation of
Plasmodium falciparum (Adjalley et al. 2010; O’Neill
et al. 2011).
In overview, transgenesis mediated by integration
competent vectors such as MLV and piggyBac can
provide a routine functional genomics platform for
forward and reverse genetics of schistosomes. For-
ward genetics, where specimens displaying a mutant
phenotype after insertional (or chemical, etc.)
mutagenesis are selected – the ‘from phenotype to
genotype’ approach – can now be attempted using
transduction of schistosomes (e.g. with MLV or
piggyBac) followed by high throughput sequence
analysis of the schistosome genome in similar fashion
to other pathogens (e.g. Langridge et al. 2009). Fur-
ther, given that draft schistosome genomes are now
available, MLV or piggyBac can be used for reverse
genetics. With reverse genetics, functional analysis
involves targeting a known gene sequence for inacti-
vationwhere the functionof thegeneof interest is then
inferred from the resulting phenotype (‘from geno-
type to phenotype’ approach) (Boutros and Ahringer,
2008). Conventional RNAi andmore recently vector-
based RNAi in schistosomes are the reverse genetic
tools of choice for reverse genetics, approaches
widely used for discovery of targets for experimental
drug and/or vaccine development (e.g. Sayed et al.
2006; Mourão et al. 2009; Stefanic et al. 2010).
VECTOR-BASED RNAi
Experimental RNAi works well in schistosomes, in
general (see Krautz-Peterson et al. 2010). Skelly and
co-workers and Boyle and colleagues first described
successful knockdown in S. mansoni (Boyle et al.
2003; Skelly et al. 2003), and since then numerous
reports describing endogenous and reporter gene
knockdown in S. mansoni and S. japonicum have
appeared (e.g. Kumagai et al. 2009; Rinaldi et al.
2009). RNAi is active in S. haematobium (Rinaldi and
co-workers, unpublished). However, conventional
RNAi by double stranded RNA frequently leads to
transient gene silencing and, in addition,may be inac-
cessible to some developmental stages and/or tissues
of schistosomes. In vivo, e.g. vector-based RNAi ap-
proaches that lead to integration of transgenes encod-
ing cassettes that express short interfering RNAs can
circumvent deficiencies with exogenous RNAi ap-
proaches by providing continuous and/or conditional
gene silencing (see Sliva and Schnierle, 2010). In
brief, these experimental systems frequently employ
a gene construct encoding an oligonucleotide of the
target siRNA, a short loop domain (*9 residues),
followed by the reverse complement of the siRNA,
and driven by a Pol III (or Pol II) promoter. The
construct can then be introduced into target cells for
endogenous expression of shRNA targeting the gene
of interest. The shRNA is processed in the cytoplasm
to siRNA (Manjunath and Dykxhoorn, 2010). Both
plasmid-based and retroviral (integrating) vectors
are widely used for vector-based RNAi procedures,
the latter offering long term gene silencing of ex-
pression (Couto andHigh, 2010; Sliva and Schnierle,
2010). Zhao and co-workers pioneered the approach
in schistosomes, demonstrating silencing of the
expression of the Mago nashi gene in S. japonicum
by siRNAs derived from shRNA expressed by
mammalian Pol III promoter H1 (Zhao et al. 2008).
We recently demonstrated that MLV encoding long
hairpin RNAs,*120 bp long (hpRNA), driven by a
RNA polymerase II promoter (S. mansoni actin)
targeting S. mansoni cathepsin B in the adult stage of
S. mansoni delivered silencing of the protease (Fig. 2,
left panel) (Tchoubrieva et al. 2010). On the other
hand, in many species including insects, mammals,
birds and pathogenic protozoa, Pol III promoter-
based DNA vectors have been employed to express
small interfering RNA (siRNA) or short hairpin
RNA (*21 bp long) (shRNA) (Lambeth et al. 2005;
Wakiyama et al. 2005; Wise et al. 2007; Linford et al.
2009). Aiming to establish vector-based RNAi
driven by a Pol III promoter, we cloned S. mansoni
and human U6 gene promoters (*270 bp) into
pLNHX driving shRNA targeting firefly luciferase.
We targeted luciferase because the effect of RNAi
against luciferase can be readily discerned (in contrast
to many endogenous genes) (Rinaldi et al. 2008).
Luciferase activity was significantly reduced in
worms transduced with piggyBac encoding shLuc
(Fig. 2, right) (Ayuk et al. 2011).
DEVELOPMENTAL STAGES OF SCHISTOSOMES
FOR TRANSGENESIS
Since developmental cycles of the three major
schistosomes of humans can be accomplished using
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laboratory rodents as the mammalian hosts and
laboratory-reared snails as the intermediate hosts
(Lewis, 1998), most developmental stages of these
schistosomes are theoretically accessible to genetic
manipulation (Fig. 3). Moreover, some stages can be
cultured ex vivo or in vitro and returned to the snails
or mice to continue development (see Mann et al.
2010). On the other hand, discrete stages are differ-
entially accessible to delivery of transgenes using
approaches including particle bombardment, square
wave electroporation, cationic polymer-based gene
delivery, and/or transduction by virions or other
infectious agents (Heyers et al. 2003; Beckmann et al.
2007; Mann et al. 2008). Other approaches, such as
microinjection, should be of value, as indicated by
progress with introduction of transgenes in tape-
worms and parasitic nematodes (Spiliotis et al. 2010).
Adult worms can be obtained from infected
rodents and can be maintaining in culture. ‘Viable’
fragments of worms – obtained by dicing adult
schistosomes into several pieces – can be used as a
study model as well (Rinaldi et al. 2011); whereas
these fragments are not as tractable as primary cell
cultures of Echinococcos multilocularis (Spiliotis et al.
2010) or fragments of planarians (Shibata et al. 2010),
they do allow access to internal organs and cells of the
schistosome. The schistosome egg and the miraci-
dium have desirable attributes for consideration in
relation to genetic manipulation, these include the
presence of a single celled zygote within the egg-shell
upon its release from the blood fluke (Jurberg et al.
2009), favourably high ratio of germ to somatic cells
even as it develops and ease of maintenance in vitro.
Primary sporocysts transformed from miracidia in
vitro are worthy targets for genomic manipulation
because this developmental stage can be transplanted
into Biomphalaria glabrata snails to establish lines
of S. mansoni (Kapp et al. 2003). Schistosomules
obtained by mechanical transformation of cercariae
shed from snails have been used to investigate the
activity of transgenes and/or schistosome gene
promoters driving transgenes (Correnti et al. 2005,
2007; Morales et al. 2007).
The ‘in vitro laid egg’ (IVLE) deserves special
mention. Pearce and colleagues demonstrated that
eggs develop after release from adult schistosomes in
vitro (Freitas et al. 2007). Eggs released from the fer-
tilized adult female schistosome can develop in vitro
and eventually release viable miracidia, provided that
the eggs have been laid soon after the adult worms
Fig. 2. Vector-based RNA interference (RNAi) in Schistosoma mansoni. Panel A: Vector-based RNAi mediated by long
hairpin RNAs (hpRNA) driven by a RNA polymerase II promoter (from the S. mansoni actin gene) carried by a
retroviral vector to knock down of the S. mansoni cathepsin B1. Top: schematic representation of retroviral vector
construct and dsRNA hairpin. Bottom: knock down of S. mansoni cathepsinB1. Panel B: Vector-based RNAi mediated
by short hairpin RNAs (shRNA) driven by a RNA polymerase III promoter (from the S. mansoni U6 gene) carried by
the piggyBac donor plasmid to knock down of the exogenous reporter gene firefly luciferase. Top: schematic
representation of construct encoding the shRNA. Bottom: knock down of reporter firefly luciferase activity. Adapted
from Tchoubrieva et al. (2010) and Ayuk et al. (2011) with permission.
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have been perfused from experimentally infected
rodents. (From about 48 hours after perfusion from
mice, eggs shed from worms exhibit reduced viabil-
ity.) Notably, when released from the female worm,
the schistosome egg includes a single cell zygote, in
which cleavage has yet to take place (Jurberg et al.
2009). Accordingly, introduction of transgenes into
this young egg may be able to accomplish germ (and
somatic) transgenesis in a developmental stage that
seems to be reasonably accessible in the laboratory
(Mann et al. 2011).
Finally, it is obvious that the availability of
immortalized cell lines would enhance functional
genomics investigations (Brindley and Pearce, 2007).
Unfortunately, none are yet available. Progress with
primary cell cultures in related flatworms (Spiliotis
et al. 2010) indicates that cell lines can be established
and perhaps progress with transgenesis of schisto-
somes with oncogenes such as hTERT (Yang et al.
2010) will provide a route forward in this area.
PERSPECTIVE
We have reviewed advances in functional genomics
and transgenesis of schistosomes, focusing on
approaches leading to chromosomal integration of
transgenes. The retrovirus MLV and the transposon
piggyBac have now both been shown to integrate
reliably into the chromosomes of S. mansoni and
hence both exhibit great potential as vectors to drive
functional genomics for schistosomes. However,
improvements are needed to establish transgenic
schistosomes and protocols. An impediment has
been the difficulty of delivering transgenes to the
germline. Targeting integration competent trans-
genes to IVLE may surmount this roadblock (Mann
et al. 2011). Other gateways to the schistosome
germline include the daughter sporocysts where the
germ cells are comparatively massive (see Coustau
and Yoshino, 2000). We envisage that advances in
technologies which will drive functional genomics
forward quickly, including expansion of in vivo
RNAi, high-throughput insertional mutagenesis
and, hopefully, gains-of-function approaches involv-
ing drug selection of transgenic schistosomes.
Advances inS. mansoni can be expected to be adapted
to the other schistosomes, to the food-borne flukes
such as Opisthorchis viverrini, Clonorchis sinensis and
Fasciola hepatica, and other helminth parasites at
large.
Fig. 3. Cartoon representation of points of the developmental cycle of Schistosoma mansoni amenable to genetic
manipulation. Both the mammalian stages involved in sexual reproduction and the snail stages with asexual reproduction
are presented. Thunder bolts suggest accessible points of introduction of transgenes into the schistosome e.g. transgene
delivery by electroporation, microinjection, etc. Black arrows indicate processes that occur naturally whereas white
arrows represent processes that can be manipulated. Dashed line indicates events inside the snail. IVLE, in vitro laid
eggs.
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